Elanco CFO granted new deferred stock units
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health’s EVP and CFO, Robert M. VanHimbergen, received a grant of 7.9380 deferred stock units on 2026-07-10 at a reference value of $24.8200 per unit. Each unit represents the right to receive one share of common stock or the cash equivalent under the Executive Deferral and Stock Match Plan and will settle after employment ends or in a specified future year. Following this award, he holds 116.7886 deferred stock units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F2 | 7.938 | $24.82 | $197.02 |
Footnotes (2)
- F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Key Figures
Key Terms
Deferred Stock Units financial
cash equivalent financial
Executive Deferral and Stock Match Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Elanco Animal Health (ELAN) report for its CFO?
Is the Elanco (ELAN) CFO’s Form 4 transaction a market purchase or sale?
How many deferred stock units does the Elanco (ELAN) CFO hold after this award?
What does each deferred stock unit represent in the Elanco (ELAN) CFO’s award?
When will the Elanco (ELAN) CFO’s deferred stock units settle?
What was the reference value used for the Elanco (ELAN) CFO’s deferred stock unit grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.